Problems with the medicalization of marijuana.
作者信息
Wilkinson Samuel T, D'Souza Deepak Cyril
机构信息
Department of Psychiatry, Yale School of Medicine, New Haven, Connecticut.
Department of Psychiatry, Yale School of Medicine, New Haven, Connecticut2Abraham Ribicoff Research Facilities, Connecticut Mental Health Center, New Haven, Connecticut3Schizophrenia and Neuropharmacology Research Group, VA Connecticut Healthcare System.
出版信息
JAMA. 2014 Jun 18;311(23):2377-8. doi: 10.1001/jama.2014.6175.
Abstract
摘要
相似文献
1
Problems with the medicalization of marijuana.大麻医学化的问题。
JAMA. 2014 Jun 18;311(23):2377-8. doi: 10.1001/jama.2014.6175.
2
Lost in the Haze: The Physician's Role in Cannabinoid Prescribing and Advising.迷失在迷雾中：医生在开具和建议使用大麻素方面的作用。
Am J Med. 2020 Jan;133(1):7-8. doi: 10.1016/j.amjmed.2019.05.049. Epub 2019 Jun 25.
3
Colorado tackles medical implications of marijuana.科罗拉多州应对大麻的医学影响。
JAMA. 2014 May;311(20):2053-4. doi: 10.1001/jama.2014.4370.
4
Medical Marijuana: Is the Cart Before the Horse?医用大麻：本末倒置了吗？
JAMA. 2015;313(24):2431-2. doi: 10.1001/jama.2015.6407.
5
Reconciling the Discrepancies in Medicine's Relationship to Medical Marijuana.调和医学与医用大麻关系中的差异
Ann Intern Med. 2018 Nov 6;169(9):646-647. doi: 10.7326/M18-1883. Epub 2018 Oct 2.
6
Medicalization of marijuana.大麻的医学化
JAMA. 2014 Nov 12;312(18):1931. doi: 10.1001/jama.2014.12563.
7
The pharmaceutical industry: friend or foe?制药行业：朋友还是敌人？
Am J Obstet Gynecol. 2008 Apr;198(4):435-9. doi: 10.1016/j.ajog.2007.11.055.
8
Medicalization of marijuana--reply.大麻的医学化——回应
JAMA. 2014 Nov 12;312(18):1931-2. doi: 10.1001/jama.2014.12569.
9
Medical Board Expectations for Physicians Recommending Marijuana.医学委员会对推荐大麻的医生的期望。
JAMA. 2016 Aug 9;316(6):577-8. doi: 10.1001/jama.2016.7741.
10
An Ethical Framework to Manage Patient Requests for Medical Marijuana.管理患者对医用大麻需求的伦理框架。
J Am Board Fam Med. 2020 Jan-Feb;33(1):147-151. doi: 10.3122/jabfm.2020.01.190216.
引用本文的文献
1
Rastafarianism: When Religious Beliefs Conflict With Medical Necessity-A Case Report and Review of the Literature Around an Ethically Complicated Case.拉斯塔法里派：当宗教信仰与医疗必要性发生冲突——一个病例报告及围绕一个伦理复杂病例的文献综述
Case Rep Psychiatry. 2025 Mar 18;2025:6621450. doi: 10.1155/crps/6621450. eCollection 2025.
2
International perspectives on physician knowledge, attitudes, and practices related to medical cannabis.关于医生对医用大麻的知识、态度和实践的国际视角。
Front Public Health. 2025 Feb 20;13:1463871. doi: 10.3389/fpubh.2025.1463871. eCollection 2025.
3
Post-legalization shifts in cannabis use among young adults in Georgia-A nationally representative study.佐治亚州年轻人在大麻合法化后的使用变化——一项全国代表性研究
Addiction. 2025 Feb;120(2):335-346. doi: 10.1111/add.16688. Epub 2024 Oct 17.
4
Identification of Novel Cannabinoid CB2 Receptor Agonists from Botanical Compounds and Preliminary Evaluation of Their Anti-Osteoporotic Effects.从植物化合物中鉴定新型大麻素 CB2 受体激动剂及其抗骨质疏松作用的初步评价。
Molecules. 2022 Jan 21;27(3):702. doi: 10.3390/molecules27030702.
5
Why Young Adults Obtain a Medical Marijuana Card: Associations with Health Symptoms and Heaviness of Use.为何年轻人会申领医用大麻卡：与健康症状及使用频率的关联。
Cannabis. 2021 Apr 22;4(1):27-39. doi: 10.26828/cannabis/2021.01.001.
6
Relationships between age at first substance use and persistence of cannabis use and cannabis use disorder.首次使用物质的年龄与大麻使用及大麻使用障碍的持续存在之间的关系。
BMC Public Health. 2021 May 27;21(1):997. doi: 10.1186/s12889-021-11023-0.
7
Evolving Global Perspectives of Pharmacists: Dispensing Medical Cannabis.全球药师视角的演变：调配医用大麻。
Cannabis Cannabinoid Res. 2022 Apr;7(2):126-134. doi: 10.1089/can.2020.0144. Epub 2021 Apr 16.
8
Correlates of patterns of cannabis use, abuse and dependence: evidence from two national surveys in Ireland.大麻使用、滥用和依赖模式的相关因素：来自爱尔兰两项全国性调查的证据。
Eur J Public Health. 2021 Apr 24;31(2):441-447. doi: 10.1093/eurpub/ckab007.
9
Evidence supporting the benefits of marijuana for Crohn's disease and ulcerative colitis is extremely limited: a meta-analysis of the literature.支持大麻对克罗恩病和溃疡性结肠炎有益的证据极为有限：一项文献荟萃分析。
Ann Gastroenterol. 2020 Sep-Oct;33(5):495-499. doi: 10.20524/aog.2020.0516. Epub 2020 Jun 22.
10
Terpenoids, Cannabimimetic Ligands, beyond the Plant.萜类化合物、拟大麻配体，超越植物。
Molecules. 2020 Mar 29;25(7):1567. doi: 10.3390/molecules25071567.
本文引用的文献
1
Marijuana use and risk of lung cancer: a 40-year cohort study.大麻使用与肺癌风险：一项长达 40 年的队列研究。
Cancer Causes Control. 2013 Oct;24(10):1811-20. doi: 10.1007/s10552-013-0259-0. Epub 2013 Jul 12.
2
Comparison of the analgesic effects of dronabinol and smoked marijuana in daily marijuana smokers.比较大麻使用者中使用大麻烟雾剂和大麻隆的镇痛效果。
Neuropsychopharmacology. 2013 Sep;38(10):1984-92. doi: 10.1038/npp.2013.97. Epub 2013 Apr 22.
3
Persistent cannabis users show neuropsychological decline from childhood to midlife.持续吸食大麻的人从儿童期到中年会出现神经认知能力下降。
Proc Natl Acad Sci U S A. 2012 Oct 2;109(40):E2657-64. doi: 10.1073/pnas.1206820109. Epub 2012 Aug 27.
4
Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia.大麻二酚增强了内源性大麻素信号传导，并缓解了精神分裂症的精神病症状。
Transl Psychiatry. 2012 Mar 20;2(3):e94. doi: 10.1038/tp.2012.15.
5
Physicians and medical marijuana.医生与医用大麻。
Am J Psychiatry. 2012 Jun;169(6):564-8. doi: 10.1176/appi.ajp.2012.12030373.
6
Opposite effects of delta-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology.大麻二酚和Δ9-四氢大麻酚对人脑功能和精神病理学的相反影响。
Neuropsychopharmacology. 2010 Feb;35(3):764-74. doi: 10.1038/npp.2009.184. Epub 2009 Nov 18.
7
Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review.大麻使用与精神性或情感性心理健康结局风险：一项系统评价
Lancet. 2007 Jul 28;370(9584):319-28. doi: 10.1016/S0140-6736(07)61162-3.
8
The cannabis withdrawal syndrome.大麻戒断综合征。
Curr Opin Psychiatry. 2006 May;19(3):233-8. doi: 10.1097/01.yco.0000218592.00689.e5.
9
Fungal contamination of tobacco and marijuana.烟草和大麻的真菌污染。
JAMA. 2000 Dec 13;284(22):2875. doi: 10.1001/jama.284.22.2875.
Zotero 插件